WNT4 and hyperandrogenism: As only 28.6% of the 60.8% of MRKH women with hyperandrogenemia in our study had acne as a clinical sign of androgen excess, a mutation within the WNT4 gene cannot be expected in the majority of our hyperandrogenemic patients.